Arcturus Therapeutics Holdings (ARCT) Shares Outstanding (2018 - 2026)

Arcturus Therapeutics Holdings' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $28.4 million for Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 4.8% year-over-year to $28.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.4 million (up 4.8% YoY) and the FY2025 annual result came in at $28.4 million, up 5.24% from the prior year.
• Shares Outstanding (Entity) was $28.4 million for Q1 2026 at Arcturus Therapeutics Holdings, roughly flat from $28.4 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $28.4 million in Q1 2026 and bottomed at $26555.0 in Q1 2023.
• A 5-year average of $22.3 million and a median of $26.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) plunged 99.9% — and 2024, when it surged 101819.17%.
• Arcturus Therapeutics Holdings' Shares Outstanding (Entity) stood at $26.6 million in 2022, then rose by 1.03% to $26.8 million in 2023, then gained by 0.64% to $27.0 million in 2024, then gained by 5.24% to $28.4 million in 2025, then gained by 0.03% to $28.4 million in 2026.
• Business Quant data shows ARCT's Shares Outstanding (Entity) at $28.4 million in Q1 2026, $28.4 million in Q4 2025, and $27.2 million in Q3 2025.